Sudarshan Chemical Industries · NSE: SUDARSCHEM · BSE: 506655

Q4 FY25 results · Jan–Mar 2025

Sudarshan Chemical Industries reported revenue from operations of ₹1,349.44 crore (up 76.6% from Q4 FY24) and net profit of ₹0.31 crore (down 99.5% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.

Consolidated · ₹ crore
Item	Q4 FY25	Q4 FY24	YoY	Q3 FY25	QoQ
Revenue from operations	1,349.44	764.24	+76.6%	666.43	+102.5%
Other income	20.45	2.98	+585.0%	4.49	+355.3%
Total income	1,369.89	767.23	+78.6%	670.92	+104.2%
Profit before share of associates & JVs and tax	7.70	78.02	−90.1%	4.69	+64.0%
Share of profit/(loss) of associates & JVs	2.87	0.00		0.00
Net profit for the period	0.31	58.03	−99.5%	0.51	−39.1%
Attributable to shareholders of the company	(4.10)	58.03	Turned loss	0.51	Turned loss
EPS, basic (₹)	7.60	8.40	not comparable	0.10	not comparable
Net margin (%)	0.0	7.6		0.1

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
Item	Q4 FY25	Q4 FY24	YoY	Q3 FY25	QoQ
Revenue from operations	703.59	617.60	+13.9%	574.78	+22.4%
Other income	17.38	3.24	+436.0%	4.43	+292.2%
Total income	720.97	620.84	+16.1%	579.22	+24.5%
Profit before tax	33.97	48.79	−30.4%	23.07	+47.2%
Net profit for the period	22.41	36.88	−39.2%	16.24	+38.0%
EPS, basic (₹)	2.90	5.30	not comparable	2.30	not comparable
Net margin (%)	3.2	6.0		2.8

Consolidated

Filed with BSE: 28 Jul 2025, 13:13 IST
Board meeting: 25 Jul 2025
Period: 01 Jan 2025 to 31 Mar 2025
Review status: Audited
Source: XBRL filing on BSE

Standalone

Filed with BSE: 28 Jul 2025, 13:13 IST
Board meeting: 25 Jul 2025
Period: 01 Jan 2025 to 31 Mar 2025
Review status: Audited
Source: XBRL filing on BSE